Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy.
about
Aldose reductase inhibitors for the treatment of diabetic polyneuropathyOlesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxelMitochondria in the pathogenesis of diabetes: a proteomic viewNeurotoxic catecholamine metabolite in nociceptors contributes to painful peripheral neuropathyTargeting neuroprotection as an alternative approach to preventing and treating neuropathic painDiabetic neuropathy: mechanisms to managementGlobal transcriptional programs in peripheral nerve endoneurium and DRG are resistant to the onset of type 1 diabetic neuropathy in Ins2 mice.Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in miceMeasurement of DCF fluorescence as a measure of reactive oxygen species in murine islets of LangerhansThe cytosolic domain of Fis1 binds and reversibly clusters lipid vesicles.Puerarin prevents high glucose-induced apoptosis of Schwann cells by inhibiting oxidative stress.Mechanisms of disease: the oxidative stress theory of diabetic neuropathyHyperglycemia- and neuropathy-induced changes in mitochondria within sensory nerves.Direct binding of the dynamin-like GTPase, Dnm1, to mitochondrial dynamics protein Fis1 is negatively regulated by the Fis1 N-terminal armGinsenoside Rb1 relieves glucose fluctuation-induced oxidative stress and apoptosis in Schwann cells.Mitochondrial configurations in peripheral nerve suggest differential ATP production.Transient receptor potential channels: targeting pain at the source.Context-Dependent Role of Mitochondrial Fusion-Fission in Clonal Expansion of mtDNA MutationsFisetin Imparts Neuroprotection in Experimental Diabetic Neuropathy by Modulating Nrf2 and NF-κB Pathways.Neurodegeneration and early lethality in superoxide dismutase 2-deficient mice: a comprehensive analysis of the central and peripheral nervous systemsIdentification of biomarkers for type 2 diabetes and its complications: a bioinformatic approach.Pathogenesis of diabetic neuropathy: bad to the bone.Aquaporin 11 insufficiency modulates kidney susceptibility to oxidative stress.Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies.Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy.High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy.Cardiac autonomic neuropathy in patients with diabetes mellitus.Dorsal Root Ganglia Sensory Neuronal Cultures: a tool for drug discovery for peripheral neuropathies.Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity.Mechanism of diabetic neuropathy: Where are we now and where to go?New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction.Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms.Mitochondrial DNA (mtDNA) biogenesis: visualization and duel incorporation of BrdU and EdU into newly synthesized mtDNA in vitro.Evaluation of Cisplatin Neurotoxicity in Cultured Rat Dorsal Root Ganglia via Cytosolic Calcium Accumulation.Selective responses of myenteric neurons to oxidative stress and diabetic stimuli.The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy.Altered Mitochondrial Anatomy of Trigeminal Ganglia Neurons in Diabetes.Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers.Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy.Extracellular Sphingomyelinase Rv0888 of Mycobacterium tuberculosis Contributes to Pathological Lung Injury of Mycobacterium smegmatis in Mice via Inducing Formation of Neutrophil Extracellular Traps.
P2860
Q24242995-026B2F99-B751-4B09-ACC8-974A117F1C74Q24646451-FCC9DEED-6F7D-44C9-ABE6-EB0D1B25DB0BQ28394886-F78A89FF-57C2-4D30-9A92-91CA36E3835FQ28568095-275841A8-8BDA-4FDB-B66A-CE702FD7A0F4Q28820780-5E3B859B-D995-42C7-9161-A7930514DD4DQ33554384-187F7F05-2672-4096-878E-737B4741B332Q33593046-B0DD4104-EAB2-46AB-949B-400B3CE3F2C1Q33764113-4F452A3F-BC2D-4F2F-B015-BA209CBFA3CEQ33771629-43E11A9E-D868-4931-97DB-CAF6448769B8Q33954852-0A73DC22-E9E6-479B-9D0A-4A05F85DBEC3Q34358231-6868C71E-A6A5-40BA-8849-D401A49D161EQ34553052-E5F89AAD-2721-4C55-A248-D1148AA04302Q34562861-802A1E29-B951-4DC3-BF2D-27994A933C2EQ34613362-BE395E5E-B42A-4F58-9724-2AEA4066C3ECQ34720246-6EF99791-27F7-48F1-87C9-69C65098436AQ34808161-12C2B3A0-1AC3-4530-B16F-A692B5F7368AQ34912798-DFC4A550-6A8B-41DB-BC07-D57BAC0DD5E3Q35634191-8ECE4272-4CB4-4744-9BD8-D6460193B137Q35785534-59802D5E-39AC-45FA-9DAA-7B880A9208E7Q36007537-F285C90D-994D-41F7-BAFB-EA2D3DB5F46EQ36735316-60AD3CB0-AF44-4340-922F-F9031D3232C4Q36796321-DC82A926-3717-4B26-A9A7-FBA396926CC3Q36836209-B8F3DFB0-806C-4D48-A05C-766291D1D0F7Q37168753-E36F2927-4D45-4288-8D7F-C8826E224FA1Q37352703-9D60BF18-1616-4AB7-B23C-BDE40C76373AQ37510406-C82C8E4D-6131-491E-BD29-566AA48C597EQ37598878-7860B0CB-A913-4D1F-A900-223024B21889Q37775522-1CD88BBE-62E4-499B-AD28-22116139CD63Q38123245-45ED6063-5433-441D-9BE2-49B902159A89Q38213041-F4CEBD95-CB2D-49CC-B8B1-B14EAF121C93Q38246170-5C3B3E4B-D34F-4F55-995C-382A690E22E3Q38253639-ABA24AE7-67CF-482E-AF8E-92F32AAF4342Q39781772-2240688F-EAAF-4F42-A862-AD4C78FA3457Q41894069-2DD92672-68DD-4FD9-81DA-3B70C9A18B23Q44897980-0DA61EA1-6E49-4A42-87F2-643B41FA75A7Q46248218-E3A1F24F-0BBF-4000-9354-868DFC4FB453Q46471274-24D15DDB-2356-4558-905F-784808048D15Q50185424-167B926F-EEEA-46A4-BFE6-5DB8A0CCFE32Q51582079-E514CD35-966B-4D06-8579-E0BAC036FB77Q52579136-6B9983D0-FD4E-4DEB-B4D7-61B8DAEBD4BE
P2860
Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy.
@ast
Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy.
@en
type
label
Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy.
@ast
Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy.
@en
prefLabel
Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy.
@ast
Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy.
@en
P2093
P2860
P356
P1476
Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy.
@en
P2093
Eva L Feldman
Gina M Leinninger
James L Edwards
Matthew J Lipshaw
P2860
P2888
P304
P356
10.1038/NCPNEURO0320
P577
2006-11-01T00:00:00Z
P6179
1006792979